Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of d-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment

Journal of NeuroVirology

Volumn 12, Issue 3, 2006, Pages 178-189

  Goodkin, Karl ^a   Vitiello, Benedetto ^b   Lyman, William D ^c,d   Asthana, Deshratn ^a   Atkinson, J Hampton ^e   Heseltine, Peter N R ^f   Molina, Rebeca ^a   Zheng, Wenli ^a   Khamis, Imad ^a   Wilkie, Frances L ^a   Shapshak, Paul ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Clinical trial; Cognition; CSF; DAPTA; HIV; Peptide T; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; NEUROPROTECTIVE AGENT; PEPTIDE T; PLACEBO; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; NEUROPROTECTION; PLASMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SERUM; STATISTICAL MODEL; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; ADULT; AIDS DEMENTIA COMPLEX; CEREBROSPINAL FLUID; FEMALE; HIV-1; HUMANS; LEUKOCYTE COUNT; MALE; MONOCYTES; PEPTIDE T; PLASMA; REPRODUCIBILITY OF RESULTS; SERUM; TREATMENT OUTCOME; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33750065423     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280600827344     Document Type: Article

References (44)

1. Antinori, A and Giancola, M and Grisetti, S and Soldani, F and Alba, L and Liuzzi, G and Amendola, A and Capobianchi, M and Tozzi, V and Perno, C. (2002) Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients AIDS, 16, pp. 1867-1876. http://www4.infotrieve.com/newmedline/ detail.asp?NameID=12351946&Session=&searchQuery=AIDS%5BJournal+ Name%5D+AND+16%5BVolume%5D+AND+1867%5BPage+Number%5D+AND+ 2002%5BPublication+Date%5D+AND+Antinori%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0856-3969&vol=16&iss= &firstpage=1867
2. Benton, A.(1974) Revised Visual Retention Test: Clinical and experimental applications, 4th ed. New York: Psychological Corp.
3. Brambilla, D and Jennings, C and Morack, R and Granger, S and Bremer, J. (2004) Comparison of the sensitivities of the version 1.5 and version 1.0 ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits at low concentrations of human immunodeficiency virus RNA J Clin Micro, 42, pp. 2819-2820. http://www.csa.com/htbin/linkabst.cgi?issn=0095-1137&vol= 42&iss=&firstpage=2819 http://dx.doi.org/ 10.1128%2FJCM.42.6.2819-2820.2004
4. Brenneman, D and Hauser, J and Spong, C and Phillips, T and Pert, C and Ruff, M. (1999) VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 gp120-induced neuronal death Brain Res, 838, pp. 27-36. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 10446313&Session=&searchQuery=Brain+Res%5BJournal+Name%5D+AND+ 838%5BVolume%5D+AND+27%5BPage+Number%5D+AND+1999%5BPublication+Date%5D+ AND+Brenneman%5BAuthor+Name%5D&count=1 http://www.csa.com/ htbin/linkabst.cgi?issn=0169-328X&vol=838&iss=&firstpage=27 http://dx.doi.org/10.1016%2FS0006-8993%2899%2901644-3
5. Brew, B and Pemberton, L and Ray, J. (2004) Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs? J NeuroVirol, 10(Suppl 1), pp. 38-43. http://www4.infotrieve.com/ newmedline/detail.asp?NameID=14982738&Session=&searchQuery=J+ NeuroVirol%5BJournal+Name%5D+AND+10%5BVolume%5D+AND+38%5BPage+Number%5D+ AND+2004%5BPublication+Date%5D+AND+Brew%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=1355-0284&vol= 10&iss=Suppl+1&firstpage=38 http://dx.doi.org/ 10.1080%2F13550280490270842
6. Centers for Disease Control and Prevention. (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR Morb Mort Weekly Rep, 41(No. RR-17), pp. 1-19. http://www.csa.com/htbin/linkabst.cgi?issn= 1546-0738&vol=41&iss=RR-17&firstpage=1
7. Escobar, I and Campo, M and Martin, J and Fernandez-Shaw, C and Pulido, F and Rubio, R. (2003) Factors affecting patient adherence to highly active antiretroviral therapy Ann Pharmacother, 37, pp. 775-781. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 12773060&Session=&searchQuery=Ann+Pharmacother%5BJournal+ Name%5D+AND+37%5BVolume%5D+AND+775%5BPage+Number%5D+AND+ 2003%5BPublication+Date%5D+AND+Escobar%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=1060-0280&vol=37&iss= &firstpage=775 http://dx.doi.org/10.1345%2Faph.1C427
8. Erali, M and Hillyard, D. (1999) Evaluation of the ultrasensitive Roche Amplicor HIV-1 Monitor assay for quantitation of human immunodeficiency type 1 RNA J Clin Micro, 37, pp. 792-795. http://www.csa.com/htbin/ linkabst.cgi?issn=0095-1137&vol=37&iss=&firstpage=792
9. Gartner, S. (2000) HIV infection and dementia Science, 287, pp. 602-604. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 10691542&Session=&searchQuery=Science%5BJournal+Name%5D+AND+ 287%5BVolume%5D+AND+602%5BPage+Number%5D+AND+2000%5BPublication+Date%5D+ AND+Gartner%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/ linkabst.cgi?issn=0294-0337&vol=287&iss=&firstpage=602 http://dx.doi.org/10.1126%2Fscience.287.5453.602
10. Gisslen, M and Fuchs, D and Svennerholm, B and Hagberg, L. (1999) Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection J Acquir Immune Defic Syndr Hum Retrovirol, 21, pp. 271-276. http://www.csa.com/ htbin/linkabst.cgi?issn=1077-9450&vol=21&iss=&firstpage=271
11. Goodkin, K and Shapshak, P and Asthana, D and Zheng, W and Concha, M and Wilkie, F and Molina, R and Lee, D and Suarez, P and Symes, S and Khamis, I. (2004) Older age and plasma viral load in HIV-1 infection AIDS, 18(Supp1), pp. S87-S98. http://www4.infotrieve.com/newmedline/ detail.asp?NameID=15075503&Session=&searchQuery=AIDS%5BJournal+ Name%5D+AND+18%5BVolume%5D+AND+S87%5BPage+Number%5D+AND+ 2004%5BPublication+Date%5D+AND+Goodkin%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0856-3969&vol= 18&iss=Supp1&firstpage=S87
12. Goodkin, K and Shapshak, P and Fujimura, R and Tuttle, R and Bradley, W and Yoshioka, M and Nagano, I and Xin, K and Kumar, A and Kumar, M and Maher, K and Asthana, D and Fletcher, M.(2000) Immune function, brain, and HIV-1 infection. In Psychoneuroimmunology: Stress, mental disorders and health. (pp. 243-316). Washington DC: American Psychiatric Press.
13. Grober, E and Silwinski, M and Korey, S. (1991) Development and validation of a model for estimating premorbid verbal intelligence in the elderly J Clin Exp Neuropsychol, 13, pp. 933-949. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 1779032&Session=&searchQuery=J+Clin+Exp+Neuropsychol%5BJournal+ Name%5D+AND+13%5BVolume%5D+AND+933%5BPage+Number%5D+AND+ 1991%5BPublication+Date%5D+AND+Grober%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0168-8634&vol=13&iss= &firstpage=933
14. Gronwall, D. (1977) Paced Auditory Serial Addition Task: A measure of recovery from concussion Percept Mot Skills, 44, pp. 367-373. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 866038&Session=&searchQuery=Percept+Mot+Skills%5BJournal+ Name%5D+AND+44%5BVolume%5D+AND+367%5BPage+Number%5D+AND+ 1977%5BPublication+Date%5D+AND+Gronwall%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0031-5125&vol=44&iss= &firstpage=367
15. He, J and Chen, Y and Farzan, M and Choe, H and Ohagen, A and Gartner, S and Busciglio, J and Yang, X and Hofmann, W and Newman, W and Mackay, C and Sodroski, J and Gabuzda, D. (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia Nature, 385, pp. 645-649. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 9024664&Session=&searchQuery=Nature%5BJournal+Name%5D+AND+ 385%5BVolume%5D+AND+645%5BPage+Number%5D+AND+1997%5BPublication+ Date%5D+AND+He%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/ linkabst.cgi?issn=0028-0887&vol=385&iss=&firstpage=645 http://dx.doi.org/10.1038%2F385645a0
16. Heseltine, P and Goodkin, K and Atkinson, J and Vitiello, B and Rochon, J and Heaton, R and Eaton, E and Wilkie, F and Sobel, E and Brown, S and Feaster, D and Schneider, L and Goldschmidts, W and Stover, E. (1998) Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment Arch Neurol, 55, pp. 41-51. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 9443710&Session=&searchQuery=Arch+Neurol%5BJournal+Name%5D+AND+ 55%5BVolume%5D+AND+41%5BPage+Number%5D+AND+1998%5BPublication+Date%5D+ AND+Heseltine%5BAuthor+Name%5D&count=1 http://www.csa.com/ htbin/linkabst.cgi?issn=0518-3707&vol=55&iss=&firstpage=41 http://dx.doi.org/10.1001%2Farchneur.55.1.41
17. Heyes, M and Saito, K and Markey, S. (1992) Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid J Biochem, 83, pp. 633-635. http://www.csa.com/htbin/linkabst.cgi?issn=0730-6652&vol= 83&iss=&firstpage=633
18. Hill, J and Mervis, R and Avidor, R and Moody, T and Brenneman, D. (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates Brain Res, 603, pp. 222-233. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 8461978&Session=&searchQuery=Brain+Res%5BJournal+Name%5D+AND+ 603%5BVolume%5D+AND+222%5BPage+Number%5D+AND+1993%5BPublication+Date%5D+ AND+Hill%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/ linkabst.cgi?issn=0169-328X&vol=603&iss=&firstpage=222 http://dx.doi.org/10.1016%2F0006-8993%2893%2991241-J
19. Hirschhorn, L and Beattie, A and Davidson, D and Agins, B.(2005). The role of viral load as a measure of the quality of care for people with HIV: The expert meeting report September92005. In [pp.]. Available from: URL: http://www.hivguidelines.org/public_html/center/quality-of-care/ viral-load-report.doc
20. Klove, H. (1963) Clinical neuropsychology Med Clin No Amer, 47, pp. 1647-1658. http://www.csa.com/htbin/linkabst.cgi?issn=0025-7125&vol= 47&iss=&firstpage=1647
21. Jackson, J and Piwowar-Manning, E and Johnson-Lewis, L and Bassett, R and Demeter, L and Brambilla, D. (2004) Comparison of versions 1.0 and 1.5 of the ultrasensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load J Clin Micro, 42, pp. 2774-2776. http://www.csa.com/htbin/ linkabst.cgi?issn=0095-1137&vol=42&iss=&firstpage=2774 http://dx.doi.org/10.1128%2FJCM.42.6.2774-2776.2004
22. McCullagh, P and Nelder, J.(1989) Generalized linear models. New York: Chapman & Hall.
23. Operskalski, E and Mosley, J and Busch, M and Stram, D. (1997) Influences of age, viral load and CD4+ count on the rate of progression of HIV-1 infection to AIDS J AIDS Hum Retrovirol, 15, pp. 243-244. http://www.csa.com/htbin/linkabst.cgi?issn=&vol=15&iss= &firstpage=243
24. Parker, E and Eaton, E and Whipple, S and Heseltine, P and Bridge, T. (1995) The University of Southern California Repeatable Episodic Memory Test J Clin Exp Neuropsychol, 17, pp. 926-936. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 8847398&Session=&searchQuery=J+Clin+Exp+Neuropsychol%5BJournal+ Name%5D+AND+17%5BVolume%5D+AND+926%5BPage+Number%5D+AND+ 1995%5BPublication+Date%5D+AND+Parker%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0168-8634&vol=17&iss= &firstpage=926
25. Pert, C and Hill, J and Ruff, M and Berman, R and Robey, W and Arthur, L and Ruscetti, F and Farrar, W. (1986) Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity Proc Natl Acad Sci U S A, 83, pp. 9254-9258. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 3097649&Session=&searchQuery=Proc+Natl+Acad+Sci+U+S+A%5BJournal+ Name%5D+AND+83%5BVolume%5D+AND+9254%5BPage+Number%5D+AND+ 1986%5BPublication+Date%5D+AND+Pert%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0027-8424&vol=83&iss= &firstpage=9254 http://dx.doi.org/10.1073%2Fpnas.83.23.9254
26. Phipps, D and MacFadden, D. (1996) Inhibition of tumour necrosis factor-alpha explains inhibition of HIV replication by peptide T AIDS, 10, pp. 919-920. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 8828750&Session=&searchQuery=AIDS%5BJournal+Name%5D+AND+ 10%5BVolume%5D+AND+919%5BPage+Number%5D+AND+1996%5BPublication+Date%5D+ AND+Phipps%5BAuthor+Name%5D&count=1 http://www.csa.com/ htbin/linkabst.cgi?issn=0856-3969&vol=10&iss=&firstpage=919
27. Ramsdale, T and Andrews, P and Nice, E. (1993) Verification of the interaction between peptide T and CD4 using surface plasmon resonance FEBS Lett, 333, pp. 217-222. http://www4.infotrieve.com/newmedline/ detail.asp?NameID=8224182&Session=&searchQuery=FEBS+ Lett%5BJournal+Name%5D+AND+333%5BVolume%5D+AND+217%5BPage+Number%5D+AND+ 1993%5BPublication+Date%5D+AND+Ramsdale%5BAuthor+Name%5D&count=1M http://www.csa.com/htbin/linkabst.cgi?issn=0014-5793&vol= 333&iss=&firstpage=217 http://dx.doi.org/ 10.1016%2F0014-5793%2893%2980657-G
28. Raychaudhuri, S and Farber, E and Raychaudhuri, S. (1999) Immunomodulatory effects of peptide T in Th1/Th2 cytokines Int J Immunopharmacol, 21, pp. 609-615. http://www4.infotrieve.com/newmedline/ detail.asp?NameID=10501630&Session=&searchQuery=Int+J+ Immunopharmacol%5BJournal+Name%5D+AND+21%5BVolume%5D+AND+609%5BPage+ Number%5D+AND+1999%5BPublication+Date%5D+AND+Raychaudhuri%5BAuthor+ Name%5D&count=1 http://www.csa.com/htbin/ linkabst.cgi?issn=0192-0561&vol=21&iss=&firstpage=609 http://dx.doi.org/10.1016%2FS0192-0561%2899%2900041-7
29. Raychaudhuri, S and Raychaudhuri, S and Farber, E. (1998) Anti-chemotactic activities of peptide-T: A possible mechanism of actions for its therapeutic effects on psoriasis Int J Immunopharmacol, 20, pp. 661-667. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 9848397&Session=&searchQuery=Int+J+Immunopharmacol%5BJournal+ Name%5D+AND+20%5BVolume%5D+AND+661%5BPage+Number%5D+AND+ 1998%5BPublication+Date%5D+AND+Raychaudhuri%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0192-0561&vol=20&iss= &firstpage=661 http://dx.doi.org/10.1016%2FS0192-0561%2898%2900020-4
30. Redwine, L and Pert, C and Rone, J and Nixon, R and Vance, M and Sandler, B and Lumpkin, M and Dieter, D and Ruff, M. (1999) Peptide T blocks gp120/CCR5 chemokine receptor-mediated chemotaxis Clin Immunol, 93, pp. 124-131. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 10527688&Session=&searchQuery=Clin+Immunol%5BJournal+Name%5D+AND+ 93%5BVolume%5D+AND+124%5BPage+Number%5D+AND+1999%5BPublication+Date%5D+ AND+Redwine%5BAuthor+Name%5D&count=1 http://www.csa.com/ htbin/linkabst.cgi?issn=1080-0549&vol=93&iss=&firstpage=124 http://dx.doi.org/10.1006%2Fclim.1999.4771
31. Reitan, R and Wolfson, D.(1985) The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation. Tucson: Neuropsychology Press.
32. Ruff, M and Melendez-Guerrero, L and Yang, Q and Ho, W and Mikovits, J and Pert, C and Ruscetti, F. (2001) Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5) Antiviral Res, 52, pp. 63-75. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 11530189&Session=&searchQuery=Antiviral+Res%5BJournal+Name%5D+ AND+52%5BVolume%5D+AND+63%5BPage+Number%5D+AND+2001%5BPublication+ Date%5D+AND+Ruff%5BAuthor+Name%5D&count=1 http://www.csa.com/ htbin/linkabst.cgi?issn=0166-3542&vol=52&iss=&firstpage=63 http://dx.doi.org/10.1016%2FS0166-3542%2801%2900163-2
33. Ruff, M and Polianova, M and Yang, Q and Leoung, G and Ruscetti, F and Pert, C. (2003) Update on D-ala-peptide T-amide (DAPTA): A viral entry inhibitor that blocks CCR5 chemokine receptors Curr HIV Res, 1, pp. 51-67. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 15043212&Session=&searchQuery=Curr+HIV+Res%5BJournal+Name%5D+AND+ 1%5BVolume%5D+AND+51%5BPage+Number%5D+AND+2003%5BPublication+Date%5D+AND+ Ruff%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/ linkabst.cgi?issn=1570-162X&vol=1&iss=&firstpage=51 http://dx.doi.org/10.2174%2F1570162033352066
34. Saag, M and Holodniy, M and Kuritzkes, D and O'Brien, W and Coombs, R and Poscher, M and Jacobsen, D and Shaw, G and Richman, D and Volberding, P. (1996) HIV viral load markers in clinical practice Nature Med, 2, pp. 625-629. http://www4.infotrieve.com/newmedline/ detail.asp?NameID=8640545&Session=&searchQuery=Nature+ Med%5BJournal+Name%5D+AND+2%5BVolume%5D+AND+625%5BPage+Number%5D+AND+ 1996%5BPublication+Date%5D+AND+Saag%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=1078-8956&vol= 2&iss=&firstpage=625 http://dx.doi.org/ 10.1038%2Fnm0696-625
35. Sacktor, N and Tarwater, P and Skolasky, R and McArthur, J and Selnes, O and Becker, J and Cohen, B and Miller, E. (2001) CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing Neurology, 57, pp. 542-544. http://www4.infotrieve.com/newmedline/ detail.asp?NameID=11502933&Session=&searchQuery= Neurology%5BJournal+Name%5D+AND+57%5BVolume%5D+AND+542%5BPage+Number%5D+ AND+2001%5BPublication+Date%5D+AND+Sacktor%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0028-3878&vol= 57&iss=&firstpage=542
36. Shapshak, P and Duncan, R and Minagar, A and Rodriguez de la Vega, P and Stewart, R and Goodkin, K. (2004) Elevated expression of IFN-gamma in the HIV-1 infected brain Front Biosci, 9, pp. 1073-1081. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 14977530&Session=&searchQuery=Front+Biosci%5BJournal+Name%5D+ AND+9%5BVolume%5D+AND+1073%5BPage+Number%5D+AND+2004%5BPublication+ Date%5D+AND+Shapshak%5BAuthor+Name%5D&count=1 http://www.csa.com/ htbin/linkabst.cgi?issn=1093-4715&vol=9&iss=&firstpage=1073
37. Singer, E and Aronow, H and Lee, S-Y and Hinkin, C and Lazarus, T. (2002) Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive) J Clin Micro, 40, pp. 3863-3864. http://www.csa.com/htbin/linkabst.cgi?issn=0095-1137&vol=40&iss= &firstpage=3863 http://dx.doi.org/10.1128%2FJCM.40.10.3863-3864.2002
38. Sodroski, J and Kowalski, M and Dorfman, T and Basiripour, L and Rosen, C and Haseltine, W. (1987) HIV envelope-CD4 interaction not inhibited by synthetic octapeptides Lancet, 1, pp. 1428-1429. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 2884513&Session=&searchQuery=Lancet%5BJournal+Name%5D+AND+ 1%5BVolume%5D+AND+1428%5BPage+Number%5D+AND+1987%5BPublication+Date%5D+ AND+Sodroski%5BAuthor+Name%5D&count=1 http://www.csa.com/ htbin/linkabst.cgi?issn=1474-4422&vol=1&iss=&firstpage=1428 http://dx.doi.org/10.1016%2FS0140-6736%2887%2990613-1
39. Sternberg, S. (1966) High speed scanning in human memory Science, 153, pp. 652-654. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 5939936&Session=&searchQuery=Science%5BJournal+Name%5D+AND+ 153%5BVolume%5D+AND+652%5BPage+Number%5D+AND+1966%5BPublication+Date%5D+ AND+Sternberg%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/ linkabst.cgi?issn=0294-0337&vol=153&iss=&firstpage=652
40. Stroop, J. (1935) Studies of interference in serial verbal reactions J Exp Psychol, 18, pp. 643-662. http://www.csa.com/htbin/linkabst.cgi?issn= 0022-1031&vol=18&iss=&firstpage=643 http://dx.doi.org/ 10.1037%2Fh0054651
41. Vandamme, A-M and Van Dooren, S and Kok, W and Goubau, P and Fransen, K and Kievits, T and Schmit, J-C and De Clercq, E and Desmyter, J. (1995) Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR J Virol Methods, 52, pp. 121-132. http://www4.infotrieve.com/newmedline/detail.asp?NameID= 7769025&Session=&searchQuery=J+Virol+Methods%5BJournal+Name%5D+ AND+52%5BVolume%5D+AND+121%5BPage+Number%5D+AND+1995%5BPublication+ Date%5D+AND+Vandamme%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0166-0934&vol=52&iss= &firstpage=121 http://dx.doi.org/10.1016%2F0166-0934%2894%2900151-6
42. Walczak, M and Imielska, D and Mackiewicz, Z and Kupryszewski, G and Dzierzanowska-Madalinska, D and Madalinski, K. (1991) The influence of D-Ala1-peptide T amide, an analogue of HIV glycoprotein 120 fragment, on the CD4-anti CD4 lymphocyte interaction Arch Immunol Ther Exp, 39, pp. 27-31. http://www.csa.com/htbin/linkabst.cgi?issn=0004-069X&vol= 39&iss=&firstpage=27
43. Wilkie, F.(1988) Computer tests for the measurement of speed of information processing. Miami: University of Miami School of Medicine.
44. Wilkie, F and Eisdorfer, C and Morgan, R and Loewenstein, D and Szapocznik, J. (1990) Cognition in early human immunodeficiency virus infection Arch Neurol, 47, pp. 433-440. http://www4.infotrieve.com/ newmedline/detail.asp?NameID=2322137&Session=&searchQuery=Arch+ Neurol%5BJournal+Name%5D+AND+47%5BVolume%5D+AND+433%5BPage+Number%5D+AND+ 1990%5BPublication+Date%5D+AND+Wilkie%5BAuthor+Name%5D&count=1 http://www.csa.com/htbin/linkabst.cgi?issn=0518-3707&vol= 47&iss=&firstpage=433